Global Enoxaparin Sodium Market Research Report 2023

Global Enoxaparin Sodium Market Research Report 2023



The global Enoxaparin Sodium market was valued at US$ 3.5 billion in 2022 and is anticipated to reach US$ 5.0 billion by 2029, witnessing a CAGR of 7.13% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Enoxaparin Sodium is estimated to increase from $ 586 million in 2023 to reach $ 840 million by 2029, at a CAGR of 6.21% during the forecast period of 2023 through 2029.

Asia-Pacific market for Enoxaparin Sodium is estimated to increase from $ 630 million in 2023 to reach $ 1.116 million by 2029, at a CAGR of 9.99% during the forecast period of 2023 through 2029.

The major global manufacturers of Enoxaparin Sodium include Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, etc. In 2022, the world's top three vendors accounted for approximately 66% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium.

The Enoxaparin Sodium market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enoxaparin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.

By Company

Sanofi

Techdow (Hepalink)

Teva

Nanjing King-friend

Rovi

Fresenius Kabi

Fosun Pharma(Gland Pharma)

Amphastar

Sandoz

Apotex

Huadong Medicine

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Segment by Type

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Segment by Channel

Hospital & Clinic

Pharmacy

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Europe

Germany

France

Poland

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

UAE

Egypt

Turkey

South Africa

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.


1 Enoxaparin Sodium Market Overview
1.1 Product Definition
1.2 Enoxaparin Sodium by Type
1.2.1 Global Enoxaparin Sodium Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium by Channel
1.3.1 Global Enoxaparin Sodium Market Value by Channel (2018 VS 2022 VS 2029)
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.4 Global Enoxaparin Sodium Market Size Estimates and Forecasts
1.4.1 Global Enoxaparin Sodium Revenue 2018-2029
1.4.2 Global Enoxaparin Sodium Sales 2018-2029
1.4.3 Global Enoxaparin Sodium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Enoxaparin Sodium Market Competition by Manufacturers
2.1 Global Enoxaparin Sodium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Enoxaparin Sodium Average Price by Manufacturers (2018-2023)
2.4 Global Key Players of Enoxaparin Sodium, Industry Ranking, 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enoxaparin Sodium, Product Type
2.7 Global Enoxaparin Sodium Market Competitive Situation and Trends
2.7.1 Global Enoxaparin Sodium Market Concentration Rate
2.7.2 The Global 5 Largest Enoxaparin Sodium Players Market Share by Revenue
2.7.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enoxaparin Sodium Market Scenario by Region
3.1 Global Enoxaparin Sodium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Enoxaparin Sodium Sales by Region: 2018-2029
3.2.1 Global Enoxaparin Sodium Sales by Region: 2018-2023
3.2.2 Global Enoxaparin Sodium Sales by Region: 2024-2029
3.3 Global Enoxaparin Sodium Revenue by Region: 2018-2029
3.3.1 Global Enoxaparin Sodium Revenue by Region: 2018-2023
3.3.2 Global Enoxaparin Sodium Revenue by Region: 2024-2029
3.4 North America Enoxaparin Sodium Market Facts & Figures by Country
3.4.1 North America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Enoxaparin Sodium Sales by Country (2018-2029)
3.4.3 North America Enoxaparin Sodium Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enoxaparin Sodium Market Facts & Figures by Country
3.5.1 Europe Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Enoxaparin Sodium Sales by Country (2018-2029)
3.5.3 Europe Enoxaparin Sodium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 Poland
3.5.7 Italy
3.5.8 Spain
3.6 Asia Pacific Enoxaparin Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Enoxaparin Sodium Market Size by Region: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Enoxaparin Sodium Sales by Region (2018-2029)
3.6.3 Asia Pacific Enoxaparin Sodium Revenue by Region (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.7 Latin America Enoxaparin Sodium Market Facts & Figures by Country
3.7.1 Latin America Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Enoxaparin Sodium Sales by Country (2018-2029)
3.7.3 Latin America Enoxaparin Sodium Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enoxaparin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Enoxaparin Sodium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Enoxaparin Sodium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Enoxaparin Sodium Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
3.8.7 Egypt
3.8.8 South Africa
4 Segment by Type
4.1 Global Enoxaparin Sodium Sales by Type (2018-2029)
4.1.1 Global Enoxaparin Sodium Sales by Type (2018-2023)
4.1.2 Global Enoxaparin Sodium Sales by Type (2024-2029)
4.1.3 Global Enoxaparin Sodium Sales Market Share by Type (2018-2029)
4.2 Global Enoxaparin Sodium Revenue by Type (2018-2029)
4.2.1 Global Enoxaparin Sodium Revenue by Type (2018-2023)
4.2.2 Global Enoxaparin Sodium Revenue by Type (2024-2029)
4.2.3 Global Enoxaparin Sodium Revenue Market Share by Type (2018-2029)
4.3 Global Enoxaparin Sodium Price by Type (2018-2029)
5 Segment by Channel
5.1 Global Enoxaparin Sodium Sales by Channel (2018-2029)
5.1.1 Global Enoxaparin Sodium Sales by Channel (2018-2023)
5.1.2 Global Enoxaparin Sodium Sales by Channel (2024-2029)
5.1.3 Global Enoxaparin Sodium Sales Market Share by Channel (2018-2029)
5.2 Global Enoxaparin Sodium Revenue by Channel (2018-2029)
5.2.1 Global Enoxaparin Sodium Revenue by Channel (2018-2023)
5.2.2 Global Enoxaparin Sodium Revenue by Channel (2024-2029)
5.2.3 Global Enoxaparin Sodium Revenue Market Share by Channel (2018-2029)
5.3 Global Enoxaparin Sodium Price by Channel (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Enoxaparin Sodium Product Portfolio
6.2 Techdow (Hepalink)
6.2.1 Techdow (Hepalink) Company Information
6.2.2 Techdow (Hepalink) Description and Business Overview
6.2.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Enoxaparin Sodium Product Portfolio
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Company Information
6.4.2 Nanjing King-friend Description and Business Overview
6.4.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
6.5 Rovi
6.5.1 Rovi Company Information
6.5.2 Rovi Description and Business Overview
6.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Rovi Enoxaparin Sodium Product Portfolio
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
6.7 Fosun Pharma(Gland Pharma)
6.7.1 Fosun Pharma(Gland Pharma) Company Information
6.7.2 Fosun Pharma(Gland Pharma) Description and Business Overview
6.7.3 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.7.4 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product Portfolio
6.8 Amphastar
6.8.1 Amphastar Company Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Amphastar Enoxaparin Sodium Product Portfolio
6.9 Sandoz (Novartis)
6.9.1 Sandoz (Novartis) Company Information
6.9.2 Sandoz (Novartis) Description and Business Overview
6.9.3 Sandoz (Novartis) Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sandoz (Novartis) Enoxaparin Sodium Product Portfolio
6.10 Apotex
6.10.1 Apotex Company Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Apotex Enoxaparin Sodium Product Portfolio
6.11 Huadong Medicine
6.11.1 Huadong Medicine Company Information
6.11.2 Huadong Medicine Description and Business Overview
6.11.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
6.12 Cipla
6.12.1 Cipla Company Information
6.12.2 Cipla Description and Business Overview
6.12.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Cipla Enoxaparin Sodium Product Portfolio
6.13 Taj Pharma
6.13.1 Taj Pharma Company Information
6.13.2 Taj Pharma Description and Business Overview
6.13.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Taj Pharma Enoxaparin Sodium Product Portfolio
6.14 Chengdu Baiyu Pharmaceutical
6.14.1 Chengdu Baiyu Pharmaceutical Company Information
6.14.2 Chengdu Baiyu Pharmaceutical Description and Business Overview
6.14.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
6.15 Changzhou Qianhong Bio-pharma
6.15.1 Changzhou Qianhong Bio-pharma Company Information
6.15.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
6.16 Beijing SL Pharmaceutical
6.16.1 Beijing SL Pharmaceutical Company Information
6.16.2 Beijing SL Pharmaceutical Description and Business Overview
6.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
7 Industry Chain and Sales Channels Analysis
7.1 Enoxaparin Sodium Industry Chain Analysis
7.2 Enoxaparin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enoxaparin Sodium Production Mode & Process
7.4 Enoxaparin Sodium Sales and Marketing
7.4.1 Enoxaparin Sodium Sales Channels
7.4.2 Enoxaparin Sodium Distributors
7.5 Enoxaparin Sodium Customers
8 Enoxaparin Sodium Market Dynamics
8.1 Enoxaparin Sodium Industry Trends
8.2 Enoxaparin Sodium Market Drivers
8.3 Enoxaparin Sodium Market Challenges and Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Enoxaparin Sodium Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 2. Global Enoxaparin Sodium Market Value by Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 3. Global Enoxaparin Sodium Market Competitive Situation by Manufacturers in 2022
Table 4. Global Enoxaparin Sodium Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Enoxaparin Sodium Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Enoxaparin Sodium Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Enoxaparin Sodium Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Enoxaparin Sodium Average Price (US$/K Units) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Enoxaparin Sodium, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enoxaparin Sodium, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Enoxaparin Sodium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 16. Global Enoxaparin Sodium Sales by Region (2018-2023) & (M Units)
Table 17. Global Enoxaparin Sodium Sales Market Share by Region (2018-2023)
Table 18. Global Enoxaparin Sodium Sales by Region (2024-2029) & (M Units)
Table 19. Global Enoxaparin Sodium Sales Market Share by Region (2024-2029)
Table 20. Global Enoxaparin Sodium Revenue by Region (2018-2023) & (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings